IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis
about
Role of cytokines and chemokines in non-alcoholic fatty liver diseaseKuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production.Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability.Over-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice.The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice.Specific contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione.Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient dietRole of choline deficiency in the Fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet.Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver diseaseNutritional recovery with a soybean diet after weaning reduces lipogenesis but induces inflammation in the liver in adult rats exposed to protein restriction during intrauterine life and lactation.LPSF/GQ-02 inhibits the development of hepatic steatosis and inflammation in a mouse model of non-alcoholic fatty liver disease (NAFLD).FOXO1 increases CCL20 to promote NF-κB-dependent lymphocyte chemotaxisSex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway.Serum biomarkers in nonalcoholic steatohepatitis: value for assessing drug effects?The CBS/CSE system: a potential therapeutic target in NAFLD?IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.A defect in the activities of Δ and Δ desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease.HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis.Brahma-related gene 1 bridges epigenetic regulation of proinflammatory cytokine production to steatohepatitis in mice.Neutralization of Interleukin-17 Attenuates Cholestatic Liver Fibrosis in Mice.Lentiviral vector-mediated down-regulation of IL-17A receptor in hepatic stellate cells results in decreased secretion of IL-6Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease.Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.The effect of β-caryophyllene on nonalcoholic steatohepatitis.Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis.Nicotinamide adenine dinucleotide phosphate (reduced) oxidase 2 modulates inflammatory vigor during nonalcoholic fatty liver disease progression in mice.
P2860
Q26830328-1A1DDFBE-66D8-46E7-A0D3-7277B490571DQ30416248-1E6380F6-EDCC-49F7-8B20-04D3ADA57FEEQ30665173-1A8866DF-15A2-47F4-964F-0C2D7583CC5CQ33817373-0BAF6767-D411-4E9D-9DD7-648B132208B2Q33831012-A188F857-BCA3-48FF-ACF3-31E7072FE248Q33897826-008A5BBA-F222-456D-8455-A922A6F0935AQ34854719-7A6566FA-7A6B-4226-A4E2-982C0561896EQ34979884-0C096507-0981-4883-8043-6535A0F36614Q34988788-1EEAB67A-5D98-4D63-B72D-FDA2C1AD121BQ35373126-FFE12B60-00B9-4E57-942D-6359CA47702FQ35415945-99AB00C9-408A-4B52-B33C-DFA6E3226665Q35776345-91E7FD0A-B667-46DF-884F-254907EA6304Q37071115-4949AFFE-5BB4-48BE-8F3D-DFF2344D27D6Q38066240-7714A554-6B7C-4A4E-B8F4-69C03874DEF1Q38286011-383AE314-4DA9-431E-AB58-49D0D05E8F5EQ39077154-2AFAAEF2-5A14-4EDE-8B0B-128C854A260DQ39096535-8B48A1C9-C4CB-443A-BC2D-96B9B4A6D6F3Q39174701-09064226-6933-4689-A294-9B03915ED739Q39217887-5EF2D929-59F6-4491-A983-4A994A04B598Q40410801-A8AFC632-708A-459E-8E85-31811A233EADQ41831049-D679477A-F6AB-458C-A314-BDBB7508AC83Q42725751-9BBFC882-B304-4EE4-B77D-B8DB0EFA5B26Q45031991-BC7B4F35-9753-4D20-8BF2-9DF09349DDE0Q45790201-DEC19EC8-9F9D-4B54-8E68-FB7F5D585FAEQ47430306-916D4BB7-FEDB-4190-B18D-5BDF66D25969Q55404905-6B4C731F-E8F4-4AA8-930A-01E499B5DB3C
P2860
IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis
@ast
IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis
@en
IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis.
@nl
type
label
IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis
@ast
IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis
@en
IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis.
@nl
prefLabel
IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis
@ast
IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis
@en
IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis.
@nl
P2093
P2860
P1433
P1476
IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis
@en
P2093
Emmanuel Mas
Marie Danjoux
Stéphane Carpentier
Thierry Levade
Virginie Garcia
P2860
P356
10.1371/JOURNAL.PONE.0007929
P407
P50
P577
2009-11-20T00:00:00Z